Tag Archive | "Sentrian"

Journal of mHealth Names Sentrian One of the Top 100 Global Digital Health Companies


Journal of mHealth Names Sentrian One of the Top 100 Global Digital Health CompaniesSentrian, a Remote Patient Intelligence company, has been selected as a 2015 Global Digital Health 100 company by the Journal of mHealth.

“Reflecting the growing prominence of mobile, digital and connected solutions in the healthcare sector, the 2015 Global Digital Health 100 includes innovative companies from 15 countries,” a statement shared with MHW reads.

Sentrian, we’re told, was recognized for its Remote Patient Intelligence (RPI) solution, designed to reduce avoidable hospitalization by leveraging the revolution in biosensors and machine learning to remotely detect health deterioration in high-risk patients earlier and with higher accuracy.
Read the full story

Posted in mHealthComments (0)

Sentrian Gets Props for Promoting Wider Adoption of Remote Patient monitoring


Sentrian Gets Props for Promoting Wider Adoption of Remote Patient monitoringIn response to its recent analysis of the remote patient monitoring market, Frost & Sullivan is turning its attention to one company.

The venerable research company is recognizing Sentrian with the 2015 North American Frost & Sullivan Award for Technology Innovation.

If you’re not familiar, Sentrian aims to make a success of RPM with its remote patient intelligence (Sentrian RPI) solution (a data-driven system that can develop the complex algorithms necessary to extract additional value from RPM).
Read the full story

Posted in Smartphones, TelemedicineComments (0)

FDA Green Lights Marketing of Sentrian Remote Patient Intelligence Solution


FDA Green Lights Marketing of Sentrian Remote Patient Intelligence SolutionFDA clearance — it’s not easy to get, but when you manage to get it, it’s a major accomplishment and a critical component in modern healthcare tech marketing.

Sentrian, a Remote Patient Intelligence company, says it has received confirmation from the Food & Drug Administration that its Remote Patient Intelligence solution reportedly meets the definition of a “medical device” for which the FDA intends to exercise “Enforcement Discretion.”

The designation identifies medical devices that “are not subject to further FDA regulatory requirements at this time” and clears the way for Sentrian to immediately begin marketing its RPI solution broadly in the U.S.
Read the full story

Posted in mHealth news, Regulation, SmartphonesComments (1)


Advert